Biogen Idec Inc (BIIB) 302.50 $BIIB
Oil Dominates; Keurig, Constellation Near Buy Points
at Investor's Business Daily - Mon Jul 21, 5:51PM CDT
Notable names dropping out of the Big Cap 20 this week include Biogen (BIIB) and Chipotle Mexican Grill (CMG), while new entrants include Canadian Pacific Railway (CP) and Magna International (MGA). Oil and gas continue to dominate this week's list,...
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 5:50PM CDT
Isis Pharmaceuticals, Inc. (ISIS) initiated a phase II study on ISIS-APO(a) in patients suffering from high lipoprotein(a) -- Lp(a).
IBD 50 Ends Week Lower But Skyworks Soars
at Investor's Business Daily - Mon Jul 21, 5:47PM CDT
The IBD 50 fell for a second straight week amid the market's recent turbulence as biotech stocks sold off. But many leading stocks continue to hold up well, and few have flashed sell signals. The index of top growth stocks fell 0.6% for the week,...
Alkermes' Pipeline Development Impresses, Key Updates Ahead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 3:40PM CDT
Alkermes (ALKS) announced the commencement of a phase I study on ALKS 8700.
Biogen Shares Rebound As Street Has A Change Of Heart
at Investor's Business Daily - Mon Jul 21, 3:09PM CDT
Biogen Idec heads into its second-quarter earnings report on one of its best rolls in years, as the biotech continues to benefit from heavy demand for its drugs to treat multiple sclerosis, cancer and autoimmune diseases. The No. 3 biotech by market...
Yellen Hates Biotech Stocks! Should You?
Brian Orelli, The Motley Fool - Motley Fool - Mon Jul 21, 1:01PM CDT
Federal Reserve Chairwoman Janet Yellen thinks your small-cap biotech is overvalued. The Fed's Monetary Policy Report, released on July 15, had this to say: [V]aluation metrics in some sectors do appear substantially stretched -- particularly...
Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 12:23PM CDT
Amgen Inc. (AMGN) announced that AMG 416 (formerly known as velcalcetide) has met the primary as well as secondary endpoints in a phase III study.
Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 8:25AM CDT
Ultragenyx (RARE) was a big mover last session, with shares rising nearly 8% on the day.
bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 7:44AM CDT
bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 10% on the day.
Facebook, Gilead Headline IBD 50's Top 5 Earnings
at Investor's Business Daily - Sat Jul 19, 7:02AM CDT
With earnings season in full force, investors should focus on the very best companies. The elite IBD 50 ranks top-rated growth stocks, factoring in strong relative price strength and top fundamentals. The IBD 50 has several companies reporting...
Why the Market is Wrong About Baxter Stock
Stephen D., Simpson,, The Motley Fool - Motley Fool - Fri Jul 18, 7:59AM CDT
Diversified health care player Baxter has done alright so far this year, up almost 10% and ahead of the S&P 500, but there is still a fair bit of skepticism on the name. Analysts continue to fret that Biogen Idec ...
Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 4:20PM CDT
Repros Therapeutics Inc. (RPRX) announced that it has received additional guidance from the FDA related to its secondary hypogonadism candidate, Androxal.
Lannett Shares Down on Subpoena Receipt from Connecticut AG - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 4:10PM CDT
Lannett Company (LCI) has received a subpeona from Connecticut AG.
CVS Caremark Forms Clinical Alliances to Boost Health Care - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 2:20PM CDT
Per the terms of the collaborations, CVS Caremark (CVS) will offer critical prescription and visit information to these healthcare providers through the secured electronic medical record (EMR) systems.
Baxter Q2 Earnings Beat Estimates, But Guidance Soft
at Investor's Business Daily - Thu Jul 17, 11:29AM CDT
Medical-product maker Baxter International (BAX) beat analysts' Q2 expectations Thursday, but its conservative guidance underwhelmed the Street. Shares dropped early but recovered and was flat in midday trading in the stock market today. Baxter's Q2...
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept
PR Newswire - Thu Jul 17, 7:40AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Medivation, Inc. (NASDAQ: MDVN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Acorda Therapeutics, Inc. (NASDAQ: ACOR) and Targacept, Inc. (NASDAQ: TRGT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4882-100free.
Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 7:31AM CDT
Ligand Pharmaceuticals has seen flat earnings estimate revisions for the current year along with a significant decline in its share price for the past month
Why Express Scripts Inc., Monster Beverage Corporation, and Biogen Idec Inc. Are Today's 3 Worst Sto
John Divine, The Motley Fool - Motley Fool - Wed Jul 16, 6:45PM CDT
Seven of the stock market's 10 sectors finished higher today, as a second day of testimony from Federal Reserve Chairwoman Janet Yellen served to assure investors that interest rates will remain low indefinitely. With that in mind, stocks seem to be...
Oil Dominates; Keurig, Constellation Near Buy Points
at Investor's Business Daily - Mon Jul 21, 5:51PM CDT
Notable names dropping out of the Big Cap 20 this week include Biogen (BIIB) and Chipotle Mexican Grill (CMG), while new entrants include Canadian Pacific Railway (CP) and Magna International (MGA). Oil and gas continue to dominate this week's list,...
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 5:50PM CDT
Isis Pharmaceuticals, Inc. (ISIS) initiated a phase II study on ISIS-APO(a) in patients suffering from high lipoprotein(a) -- Lp(a).
IBD 50 Ends Week Lower But Skyworks Soars
at Investor's Business Daily - Mon Jul 21, 5:47PM CDT
The IBD 50 fell for a second straight week amid the market's recent turbulence as biotech stocks sold off. But many leading stocks continue to hold up well, and few have flashed sell signals. The index of top growth stocks fell 0.6% for the week,...
Alkermes' Pipeline Development Impresses, Key Updates Ahead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 3:40PM CDT
Alkermes (ALKS) announced the commencement of a phase I study on ALKS 8700.
Biogen Shares Rebound As Street Has A Change Of Heart
at Investor's Business Daily - Mon Jul 21, 3:09PM CDT
Biogen Idec heads into its second-quarter earnings report on one of its best rolls in years, as the biotech continues to benefit from heavy demand for its drugs to treat multiple sclerosis, cancer and autoimmune diseases. The No. 3 biotech by market...
Yellen Hates Biotech Stocks! Should You?
Brian Orelli, The Motley Fool - Motley Fool - Mon Jul 21, 1:01PM CDT
Federal Reserve Chairwoman Janet Yellen thinks your small-cap biotech is overvalued. The Fed's Monetary Policy Report, released on July 15, had this to say: [V]aluation metrics in some sectors do appear substantially stretched -- particularly...
Amgen's AMG 416 Succeeds in Phase III, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 12:23PM CDT
Amgen Inc. (AMGN) announced that AMG 416 (formerly known as velcalcetide) has met the primary as well as secondary endpoints in a phase III study.
Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 8:25AM CDT
Ultragenyx (RARE) was a big mover last session, with shares rising nearly 8% on the day.
bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jul 21, 7:44AM CDT
bluebird bio, Inc. (BLUE) was a big mover last session, as the company saw its shares surge over 10% on the day.
Facebook, Gilead Headline IBD 50's Top 5 Earnings
at Investor's Business Daily - Sat Jul 19, 7:02AM CDT
With earnings season in full force, investors should focus on the very best companies. The elite IBD 50 ranks top-rated growth stocks, factoring in strong relative price strength and top fundamentals. The IBD 50 has several companies reporting...
Why the Market is Wrong About Baxter Stock
Stephen D., Simpson,, The Motley Fool - Motley Fool - Fri Jul 18, 7:59AM CDT
Diversified health care player Baxter has done alright so far this year, up almost 10% and ahead of the S&P 500, but there is still a fair bit of skepticism on the name. Analysts continue to fret that Biogen Idec ...
Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 4:20PM CDT
Repros Therapeutics Inc. (RPRX) announced that it has received additional guidance from the FDA related to its secondary hypogonadism candidate, Androxal.
Lannett Shares Down on Subpoena Receipt from Connecticut AG - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 4:10PM CDT
Lannett Company (LCI) has received a subpeona from Connecticut AG.
CVS Caremark Forms Clinical Alliances to Boost Health Care - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 2:20PM CDT
Per the terms of the collaborations, CVS Caremark (CVS) will offer critical prescription and visit information to these healthcare providers through the secured electronic medical record (EMR) systems.
Baxter Q2 Earnings Beat Estimates, But Guidance Soft
at Investor's Business Daily - Thu Jul 17, 11:29AM CDT
Medical-product maker Baxter International (BAX) beat analysts' Q2 expectations Thursday, but its conservative guidance underwhelmed the Street. Shares dropped early but recovered and was flat in midday trading in the stock market today. Baxter's Q2...
Technical Update, Leadership Appointments, Therapy Approvals, Notifications, and Clinical Trial Results - Analyst Notes on Biogen, Medivation, BioMarin, Acorda and Targacept
PR Newswire - Thu Jul 17, 7:40AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Medivation, Inc. (NASDAQ: MDVN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Acorda Therapeutics, Inc. (NASDAQ: ACOR) and Targacept, Inc. (NASDAQ: TRGT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4882-100free.
Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 7:31AM CDT
Ligand Pharmaceuticals has seen flat earnings estimate revisions for the current year along with a significant decline in its share price for the past month
Why Express Scripts Inc., Monster Beverage Corporation, and Biogen Idec Inc. Are Today's 3 Worst Sto
John Divine, The Motley Fool - Motley Fool - Wed Jul 16, 6:45PM CDT
Seven of the stock market's 10 sectors finished higher today, as a second day of testimony from Federal Reserve Chairwoman Janet Yellen served to assure investors that interest rates will remain low indefinitely. With that in mind, stocks seem to be...
